Diagnostic value of myocardial myoglobin C (CMYBPC), a novel myocardial injury marker, in coronary atherosclerotic heart disease

Early diagnostic value of cMyBPC in patients with suspected acute myocardial infraction

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043234

Enrollment

Unknown

Registered

2021-02-09

Start date

2021-02-04

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease, especially acute myocardial infarction

Interventions

Gold Standard:cTnI,coronary angiography

Index test:cMyBPC

Sponsors

The Second Affiliated Hospital of Nanjing Medical University

Lead Sponsor

Eligibility

Sex/Gender

All

Age

18 Years to 88 Years

Inclusion criteria

Inclusion criteria: Admission with symptoms associated with coronary artery disease, such as chest pain, chest tightness, precardiac discomfort, palpitations, wheezing, dyspnea, upper abdomen, neck, jaw, or arm pain.

Exclusion criteria

Exclusion criteria: ACS, ESRD, dialysis, and various connective tissue diseases, infections, trauma and malignant tumors occurred within 30 days before the onset.

Design outcomes

Primary

Measure	Time frame
AMI;SEN, SPE, ACC, AUC of ROC, PPV, NPV;	—

Countries

China

Contacts

Public ContactZhang Haiyan

The Second Affiliated Hospital of Nanjing Medical University

zhanghy198032@sina.com+86 13851799121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026